Best Clinicaltrials Podcasts (2024)

1
Treating Septic Shock with Nanoparticle Formulation that Redistributes Nitric Oxide with Dr. Harven DeShield Vivacelle Bio TRANSCRIPT

1h ago

—

Dr. Harven DeShield is the CEO and Co-Founder of Vivacelle Bio, which is developing a nanoparticle-based treatment called VBI-S to address the underlying causes of septic shock. The treatment works by efficiently redistributing nitric oxide to help regulate blood pressure and improve organ function, reducing the need for traditional vasopressor tre…

1
Treating Septic Shock with Nanoparticle Formulation that Redistributes Nitric Oxide with Dr. Harven DeShield Vivacelle Bio 19:42

8h ago19:42

19:42

Dr. Harven DeShield is the CEO and Co-Founder of Vivacelle Bio, which is developing a nanoparticle-based treatment called VBI-S to address the underlying causes of septic shock. The treatment works by efficiently redistributing nitric oxide to help regulate blood pressure and improve organ function, reducing the need for traditional vasopressor tre…

1
Episode 487 - Sue Liss 12:19

3h ago12:19

12:19

PAH patient and Chicago-area support group leader, Sue Liss, discusses her pulmonary arterial hypertension diagnosis. Sue is involved with multiple PH related advocacy groups. Through these groups, she offers support and guidance, particularly in navigating medication funding challenges and accessing the right care, emphasizing the importance of co…

1
Sep 20 2024 This Week in Cardiology 22:39

4h ago22:39

22:39

Listener feedback, K levels post cardiac surgery, cardiac device safety, disparities in preventive care, stopping trials early, and a SHAM-PVI update are the topics John Mandrola, MD, covers this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. List…

1
Innovation in the EHR Landscape to Break Down Data Silos and Improve the Healthcare Provider Experience with Sandra Johnson CliniComp TRANSCRIPT

2h ago

—

Sandra Johnson, the Senior Vice President of Client Services at CliniComp, discusses the evolving landscape of electronic health records (EHRs) and the need for interoperability and customization to meet clinicians' needs. She emphasizes the importance of putting clinicians first and involving them in the software development process from the begin…

1
Innovation in the EHR Landscape to Break Down Data Silos and Improve the Healthcare Provider Experience with Sandra Johnson CliniComp 17:23

3h ago17:23

17:23

Sandra Johnson, the Senior Vice President of Client Services at CliniComp, discusses the evolving landscape of electronic health records (EHRs) and the need for interoperability and customization to meet clinicians' needs. She emphasizes the importance of putting clinicians first and involving them in the software development process from the begin…

1
How Pressure Mapping Technology is Revolutionizing Pressure Injury Prevention in Hospitals with Kathy Gunn Wellsense TRANSCRIPT

3h ago

—

Kathy Gunn, VP of commercial and clinical operations at Wellsense, discusses the pressure mapping system Wellsense developed to prevent pressure injuries caused by support surfaces, offloading devices, and medical equipment. The pressure mapping technology works by installing an overlay into existing support surfaces, which sends real-time pressure…

1
How Pressure Mapping Technology is Revolutionizing Pressure Injury Prevention in Hospitals with Kathy Gunn Wellsense 19:02

38m ago19:02

19:02

Kathy Gunn, VP of commercial and clinical operations at Wellsense, discusses the pressure mapping system Wellsense developed to prevent pressure injuries caused by support surfaces, offloading devices, and medical equipment. The pressure mapping technology works by installing an overlay into existing support surfaces, which sends real-time pressure…

1
Campaign to Promote Genetic and Biomarker Testing for Breast Cancer with Jean Sachs Living Beyond Breast Cancer TRANSCRIPT

3d ago

—

Jean Sachs, CEO of Living Beyond Breast Cancer, a national nonprofit organization dedicated to addressing disparities in cancer treatment and providing resources and support for individuals diagnosed with breast cancer. LBBC is part of the No One Missed breast cancer campaign, which aims to raise awareness about the importance of biomarker testing …

1
Campaign to Promote Genetic and Biomarker Testing for Breast Cancer with Jean Sachs Living Beyond Breast Cancer 17:22

2h ago17:22

17:22

Jean Sachs, CEO of Living Beyond Breast Cancer, a national nonprofit organization dedicated to addressing disparities in cancer treatment and providing resources and support for individuals diagnosed with breast cancer. LBBC is part of the No One Missed breast cancer campaign, which aims to raise awareness about the importance of biomarker testing …

1
Episode 486 - Scott E. Olitsky, MD 8:51

1d ago8:51

8:51

In this episode, Dr. Scott Olitsky, the Global Center of Excellence Outreach Director for Cure HHT, discusses hereditary hemorrhagic telangiectasia (HHT), a genetic disease characterized by abnormal blood vessel development. HHT can cause bleeding in various parts of the body, with nosebleeds being the most common symptom. In some cases, HHT can le…

1
Regeneration in the CNS to Recover Function from Spinal Cord Injury with Dr. Monica Perez Shirley Ryan AbilityLab TRANSCRIPT

2d ago

—

Dr. Monica Perez, the Scientific Chair at the Arms and Hands Lab at the Shirley Ryan AbilityLab and Professor of Physical Medicine and Rehabilitation at Northwestern University, is focused on developing drugs and strategies for treating those with spinal cord injuries. With no FDA-approved treatment, the current standard of care is surgery and phys…

1
Regeneration in the CNS to Recover Function from Spinal Cord Injury with Dr. Monica Perez Shirley Ryan AbilityLab 16:38

5h ago16:38

16:38

Dr. Monica Perez, the Scientific Chair at the Arms and Hands Lab at the Shirley Ryan AbilityLab and Professor of Physical Medicine and Rehabilitation at Northwestern University, is focused on developing drugs and strategies for treating those with spinal cord injuries. With no FDA-approved treatment, the current standard of care is surgery and phys…

1
Journal Editorial - Familial hypercholesterolaemia: need for equitable treatment in women and men 7:21

1h ago7:21

7:21

With Raul Santos, Hospital Israelita Albert Einstein, Sao Paulo - Brazil. Link to Editorial Link to PaperBy European Society of Cardiology

1
Sep 13 2024 This Week in Cardiology 25:49

5h ago25:49

25:49

More from ESC: the SCOFF trial and fasting before cardiac cath, MATTERHORN, humbling data with AI, plus a reflection on the work of being a patient are the topics John Mandrola, MD, covers this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Fastin…

1
Future of Prescription Digital Therapeutics with Richard Kedziora Estenda Solutions TRANSCRIPT

1h ago

—

Richard ‘RJ’ Kedziora, Co-Founder, CEO, and Chief People Officer at Estenda Solutions, emphasizes that usability is critical in developing successful digital therapeutics, and industry standards and interoperability are essential for data sharing and integration. A digital therapeutic can be prescribed by a physician and reimbursed by insurance com…

1
Future of Prescription Digital Therapeutics with Richard Kedziora Estenda Solutions 17:27

5d ago17:27

17:27

Richard ‘RJ’ Kedziora, Co-Founder, CEO, and Chief People Officer at Estenda Solutions, emphasizes that usability is critical in developing successful digital therapeutics, and industry standards and interoperability are essential for data sharing and integration. A digital therapeutic can be prescribed by a physician and reimbursed by insurance com…

1
Focusing on Synthetic Lethality and Targeting the DNA Damage Response Pathway to Kill Cancer Cells with Oren Gilad Aprea Therapeutics TRANSCRIPT

18h ago

—

Oren Gilad, President and CEO of Aprea Therapeutics, focused on the DNA damage response pathway, specifically targeting the ATR protein. ATR is a master regulator of DNA replication and is hyperactive in cancer cells, making it a potential Achilles heel for cancer therapy. By inhibiting ATR, cancer cells can be selectively targeted, while normal ce…

1
Focusing on Synthetic Lethality and Targeting the DNA Damage Response Pathway to Kill Cancer Cells with Oren Gilad Aprea Therapeutics 17:34

19h ago17:34

17:34

Oren Gilad, President and CEO of Aprea Therapeutics, focused on the DNA damage response pathway, specifically targeting the ATR protein. ATR is a master regulator of DNA replication and is hyperactive in cancer cells, making it a potential Achilles heel for cancer therapy. By inhibiting ATR, cancer cells can be selectively targeted, while normal ce…

1
How Providing In-Home Acute Care Services Reduces Time Needed in Hospitals with Dr. Marcy Carty myLaurel TRANSCRIPT

2d ago

—

Dr. Marcy Carty, President and Chief Medical Officer of myLaurel, emphasizes the need to change the model where hospitals are the safest place for medical care. MyLaurel's acute care services include pre-hospital care to prevent emergency room visits, care-at-home to help patients get discharged earlier, and post-hospitalization care to smooth the …

1
How Providing In-Home Acute Care Services Reduces Time Needed in Hospitals with Dr. Marcy Carty myLaurel 16:57

8d ago16:57

16:57

Dr. Marcy Carty, President and Chief Medical Officer of myLaurel, emphasizes the need to change the model where hospitals are the safest place for medical care. MyLaurel's acute care services include pre-hospital care to prevent emergency room visits, care-at-home to help patients get discharged earlier, and post-hospitalization care to smooth the …

1
Expanding Access to Vital Cardiac Screening with Dr. Waqaas Al-Siddiq Biotricity TRANSCRIPT

3d ago

—

Dr. Waqaas Al-Siddiq, the CEO and Founder of Biotricity, focuses on remote patient monitoring for heart health with HeartSecure, the three-channel wearable device that collects continuous ECG data. This device provides a more comprehensive view of the electrical activity of the heart compared to other wearables like smartwatches and can help identi…

1
Expanding Access to Vital Cardiac Screening with Dr. Waqaas Al-Siddiq Biotricity 18:32

3d ago18:32

18:32

Dr. Waqaas Al-Siddiq, the CEO and Founder of Biotricity, focuses on remote patient monitoring for heart health with HeartSecure, the three-channel wearable device that collects continuous ECG data. This device provides a more comprehensive view of the electrical activity of the heart compared to other wearables like smartwatches and can help identi…

1
Episode 485 - Eric Borstein 11:10

4d ago11:10

11:10

Eric Borstein, who lives with pulmonary arterial hypertension, is walking from Los Angeles to San Diego to raise funds and awareness for the benefit of Team PHenomenal Hope. On September 21st, 2020, while at home, he collapsed from massive right heart failure and almost died. On September 22nd, 2024, four years after his PH diagnosis, he begin his …

1
Urging Medicare to Maintain Coverage of Skin Substitutes for Chronic Wound Care Treatments with Bill Padula and Dr. David Armstrong University of Southern California TRANSCRIPT

4d ago

—

Bill Padula, PhD, Assistant Professor of Pharmaceutical and Health Economics, and Dr. David Armstrong, professor of surgery and Neurological surgery, are both at the University of Southern California and are concerned about wound care and the impact of potential changes in Medicare reimbursement of skin substitutes. They discuss the importance of s…

1
Urging Medicare to Maintain Coverage of Skin Substitutes for Chronic Wound Care Treatments with Bill Padula and Dr. David Armstrong University of Southern California 21:21

14d ago21:21

21:21

Bill Padula, PhD, Assistant Professor of Pharmaceutical and Health Economics, and Dr. David Armstrong, professor of surgery and Neurological surgery, are both at the University of Southern California and are concerned about wound care and the impact of potential changes in Medicare reimbursement of skin substitutes. They discuss the importance of s…

1
Journal Editorial - Valvular heart disease: the oncoming tsunami 6:16

4d ago6:16

6:16

With Kwan-Leung CHAN & Lawrence Lau, University of Ottawa Heart institute - Canada. Link to editorial Link to paperBy European Society of Cardiology

1
Sep 06 2024 This Week in Cardiology 30:21

15d ago30:21

30:21

Feedback on ABYSS and beta-blockers, more ESC recap, including SHAM-PVI, FINEARTS-HF, and RESHAPE HF2 trials are the topics John Mandrola, MD, discusses in today’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Feedback on ABYSS Setbacks After …

Podcasts Worth a Listen

Clinicaltrials Podcasts

Podcasts Worth a Listen

Quick Reference Guide